FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000960173> ?p ?o ?g. }

• W2000960173 endingPage "95" @default.
• W2000960173 startingPage "88" @default.
• W2000960173 abstract "PURPOSE: We conducted a phase I trial of escalating doses of topotecan (TOPO) in association with a fixed systemic exposure of carboplatin (CARBO) with or without granulocyte colony-stimulating factor (G-CSF) in children. PATIENTS AND METHODS: Two separate cohorts of patients (pts) with solid tumors were studied: (A) pts with refractory or recurrent disease and (B) pts with no prior myelosuppressive therapy or newly diagnosed tumors for which there was no standard chemotherapy. CARBO was given on day 1 at an area under the curve of 6.5, followed by TOPO as a continuous infusion for 3 days; the starting dose of TOPO was 0.50 mg/m2/d. Cycles were repeated every 21 days. G-CSF was given at a dose of 5 μg/kg/d starting on day 4. RESULTS: Forty-eight of 51 pts were assessable for toxicity. In group A, dose-limiting myelosuppression persisted despite de-escalation of TOPO to 0.3 mg/m2/d and use of G-CSF. In group B, the maximum-tolerated dose of TOPO was 0.5 mg/m2/d for 3 days, and 0.6 mg/m2/d for 3 days with G-CSF. No significant nonhematologic toxicities were observed. Among 46 pts assessable for response, one had complete response, five had partial response, and 18 had stable disease. CONCLUSION: Although this combination possesses antineoplastic activity in pediatric solid tumors, hematologic toxicity precluded any meaningful TOPO dose escalation. The addition of G-CSF did not alter this. The potential for preservation of activity and diminution of toxicity with alternative sequences and schedules of administration (topoisomerase followed by alkylating or platinating agents) should be evaluated." @default.
• W2000960173 created "2016-06-24" @default.
• W2000960173 creator A5007133821 @default.
• W2000960173 creator A5013494474 @default.
• W2000960173 creator A5020203091 @default.
• W2000960173 creator A5039864062 @default.
• W2000960173 creator A5043293908 @default.
• W2000960173 creator A5048306141 @default.
• W2000960173 creator A5065566520 @default.
• W2000960173 creator A5078718051 @default.
• W2000960173 date "2002-01-01" @default.
• W2000960173 modified "2023-10-10" @default.
• W2000960173 title "Phase I Study of Combination Topotecan and Carboplatin in Pediatric Solid Tumors" @default.
• W2000960173 cites W1586329649 @default.
• W2000960173 cites W1851083905 @default.
• W2000960173 cites W1864471800 @default.
• W2000960173 cites W1876840442 @default.
• W2000960173 cites W1893281004 @default.
• W2000960173 cites W1894280592 @default.
• W2000960173 cites W1909276731 @default.
• W2000960173 cites W1914432880 @default.
• W2000960173 cites W1931620667 @default.
• W2000960173 cites W1952453258 @default.
• W2000960173 cites W1980560578 @default.
• W2000960173 cites W1995024307 @default.
• W2000960173 cites W1995123671 @default.
• W2000960173 cites W1996583014 @default.
• W2000960173 cites W2002314919 @default.
• W2000960173 cites W2017739390 @default.
• W2000960173 cites W2043363330 @default.
• W2000960173 cites W2043703023 @default.
• W2000960173 cites W2045919099 @default.
• W2000960173 cites W2066933615 @default.
• W2000960173 cites W2094864265 @default.
• W2000960173 cites W2102345056 @default.
• W2000960173 cites W2116996913 @default.
• W2000960173 cites W2120356362 @default.
• W2000960173 cites W2120883034 @default.
• W2000960173 cites W2140435453 @default.
• W2000960173 cites W2162629228 @default.
• W2000960173 cites W2167974749 @default.
• W2000960173 cites W2225051375 @default.
• W2000960173 cites W2227545313 @default.
• W2000960173 cites W2257426985 @default.
• W2000960173 cites W2273425405 @default.
• W2000960173 cites W2288042566 @default.
• W2000960173 cites W2410735442 @default.
• W2000960173 cites W2416555132 @default.
• W2000960173 cites W2418854645 @default.
• W2000960173 cites W305459207 @default.
• W2000960173 doi "https://doi.org/10.1200/jco.20.1.88" @default.
• W2000960173 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11773158" @default.
• W2000960173 hasPublicationYear "2002" @default.
• W2000960173 type Work @default.
• W2000960173 sameAs 2000960173 @default.
• W2000960173 citedByCount "20" @default.
• W2000960173 countsByYear W20009601732012 @default.
• W2000960173 countsByYear W20009601732015 @default.
• W2000960173 countsByYear W20009601732016 @default.
• W2000960173 countsByYear W20009601732017 @default.
• W2000960173 countsByYear W20009601732018 @default.
• W2000960173 countsByYear W20009601732019 @default.
• W2000960173 crossrefType "journal-article" @default.
• W2000960173 hasAuthorship W2000960173A5007133821 @default.
• W2000960173 hasAuthorship W2000960173A5013494474 @default.
• W2000960173 hasAuthorship W2000960173A5020203091 @default.
• W2000960173 hasAuthorship W2000960173A5039864062 @default.
• W2000960173 hasAuthorship W2000960173A5043293908 @default.
• W2000960173 hasAuthorship W2000960173A5048306141 @default.
• W2000960173 hasAuthorship W2000960173A5065566520 @default.
• W2000960173 hasAuthorship W2000960173A5078718051 @default.
• W2000960173 hasConcept C121332964 @default.
• W2000960173 hasConcept C126322002 @default.
• W2000960173 hasConcept C141071460 @default.
• W2000960173 hasConcept C142424586 @default.
• W2000960173 hasConcept C2776694085 @default.
• W2000960173 hasConcept C2777767877 @default.
• W2000960173 hasConcept C2778239845 @default.
• W2000960173 hasConcept C2781209748 @default.
• W2000960173 hasConcept C2781451048 @default.
• W2000960173 hasConcept C29730261 @default.
• W2000960173 hasConcept C71924100 @default.
• W2000960173 hasConcept C87355193 @default.
• W2000960173 hasConcept C90924648 @default.
• W2000960173 hasConceptScore W2000960173C121332964 @default.
• W2000960173 hasConceptScore W2000960173C126322002 @default.
• W2000960173 hasConceptScore W2000960173C141071460 @default.
• W2000960173 hasConceptScore W2000960173C142424586 @default.
• W2000960173 hasConceptScore W2000960173C2776694085 @default.
• W2000960173 hasConceptScore W2000960173C2777767877 @default.
• W2000960173 hasConceptScore W2000960173C2778239845 @default.
• W2000960173 hasConceptScore W2000960173C2781209748 @default.
• W2000960173 hasConceptScore W2000960173C2781451048 @default.
• W2000960173 hasConceptScore W2000960173C29730261 @default.
• W2000960173 hasConceptScore W2000960173C71924100 @default.
• W2000960173 hasConceptScore W2000960173C87355193 @default.
• W2000960173 hasConceptScore W2000960173C90924648 @default.
• W2000960173 hasIssue "1" @default.

• next